Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Diagnosis of progressive familial intrahepatic cholestasis in adulthood
6
Mins
September 2024
Progressive familial intrahepatic cholestasis (PFIC) is a cholestatic condition that typically arises in childhood. As such, if an adult…
Read more
6
Mins
28 May 2019
Management of Hepatitis C in People Who Inject Drugs: Some Practical Lessons from the Frontline of the Elimination Battle
One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…
9
Mins
28 May 2019
Procedural Risk of Bleeding: Does the Management of Thrombocytopenia in Chronic Liver Disease Patients Make a Difference? A Debate
Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…
18
Mins
28 May 2019
Editor's Pick: Overview of Alpha-1 Antitrypsin Deficiency-Mediated Liver Disease
This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…
6
Mins
28 May 2019
Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…
7
Mins
28 May 2019
Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related Nephropathy
The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…
9
Mins
28 May 2019
Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis
The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…
13
Mins
28 May 2019
Liver Fibrosis: A Clinical Update
Liver fibrosis is the common sequelae of chronic insult to the liver from any aetiology. The most common causes are alcohol-related, fatty liver disease…
9
Mins
28 Sep 2018
Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time
Transjugular intrahepatic portosystemic shunt. Portal hypertension is the main complication of cirrhosis and occurs due to increased pressure within the…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
17
Next »